AusperBio completes patient enrollment in phase III AUSHINE study of AHB-137 for chronic hepatitis B
AusperBio completes patient enrollment in phase III AUSHINE study of AHB-137 for chronic hepatitis B: San Francisco Tuesday, December 23, 2025, 15:00 Hrs [IST] AusperBio Therapeut ...
Clinical Trials Arena on MSN
AusperBio concludes enrolment in Phase III AUSHINE trial
In September 2025, AusperBio completed participant enrolment in two Phase II studies evaluating AHB-137 for the functional cure of CHB. "AusperBio concludes enrolment in Phase III AUSHINE trial" was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback